Nuerbiyemu Maimaitiaili
Overview
Explore the profile of Nuerbiyemu Maimaitiaili including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
13
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zeng Y, Zhakeer G, Li B, Yu Q, Niu M, Maimaitiaili N, et al.
Front Cardiovasc Med
. 2024 Jan;
10:1290895.
PMID: 38259305
Background: High-altitude pulmonary hypertension (HAPH) is a common disease in regions of high altitude where performing right heart catheterization (RHC) is challenging. The development of a diagnostic scoring system is...
2.
Maimaitiaili N, Zeng Y, Ju P, Zhakeer G, E G, Yao H, et al.
Exp Cell Res
. 2023 Aug;
431(2):113755.
PMID: 37586455
Hypoxia-induced pulmonary hypertension is a subgroup of type 3 pulmonary hypertension (PH) with the recommended treatment limited to oxygen therapy and lacks potential therapeutic targets. To investigate the role of...
3.
Yu Q, Ju P, Kou W, Zhai M, Zeng Y, Maimaitiaili N, et al.
JACC Basic Transl Sci
. 2023 Jun;
8(5):479-496.
PMID: 37325412
Macrophages regulate inflammation and the process of tissue repair. Therefore, a better understanding of macrophages in the pathogenesis of heart failure is needed. In patients with hypertrophic cardiomyopathy, NLRC5 was...
4.
Zeng Y, Yu Q, Maimaitiaili N, Li B, Liu P, Hou Y, et al.
JACC Asia
. 2023 Jan;
2(7):803-815.
PMID: 36713752
Background: High-altitude pulmonary hypertension (HAPH), as the group 3 pulmonary hypertension, has been less studied so far. The limited medical conditions in the high-altitude plateau are responsible for the delay...
5.
Zhong Y, Tang K, Nattel S, Zhai M, Gong S, Yu Q, et al.
Redox Biol
. 2023 Jan;
60:102606.
PMID: 36645977
Objectives: To determine the role of MYL4 regulation of lysosomal function and its disturbance in fibrotic atrial cardiomyopathy. Background: We have previously demonstrated that the atrial-specific essential light chain protein...